HemaSphere (Jun 2022)

S302: COST-EFFECTIVENESS OF KTE-X19 IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA

  • M. Marchetti,
  • C. Visco

DOI
https://doi.org/10.1097/01.HS9.0000844100.62990.c2
Journal volume & issue
Vol. 6
pp. 203 – 204

Abstract

Read online

No abstracts available.